Atara Biotherapeutics Inc is a company in the U.S. stock market and it is a holding in 36 U.S.-traded ETFs. ATRA has around 6.2M shares in the U.S. ETF market. The largest ETF holder of ATRA is the SPDR S&P Biotech ETF (XBI), with approximately 2.00M shares. Investors may also find of interest that the ETF with the largest allocation to ATRA stock is Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a portfolio weight of 1.12%. On average, U.S. ETFs allocate 0.10% of ATRA to their portfolios.
Additionally, ATRA is a favorite stock for Vanilla and Equal ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ATRA as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 48.93%.